TP53 and colorectal carcinoma: reported that the Wnt pathway, Notch pathway, and TP53 mutations interact and maintain a balance to promote CRC progression.[37] Wnt pathway involves complicated regulatory networks, and targeting this crucial point may be a key step in the successful disruption of this pathway.